Join us on June 23rd from 12:30pm – 1:30pm ET for a webinar titled, “Pharmacokinetics 101: Introducing Multiple-Dose PK & Bioavailability.” Nuventra’s Director of Pharmacokinetics, Scott Brantley, Ph.D., will lead the session.
Multiple-dose studies are one of the earliest studies performed in the clinical development stage of a drug. They are intended to fully characterize the PK of a drug and its metabolites at steady state. Bioavailability studies should also be conducted early in the drug development process to guide and select formulations for further development.
At the end of this webinar, attendees should have a better understanding of:
- ADME overview
- Multiple-dose PK parameters
- Plotting multiple-dose data
- Bioavailability & bioequivalence
- Food effect studies
This event is free of charge.
Meet the Presenter
Scott Brantley, Ph.D.
Dr. Brantley has over 8 years of experience in clinical and nonclinical pharmacology, pharmacokinetics, pharmacometrics, and scientific writing. Dr. Brantley’s focus is mainly in early phase oncology and antiviral programs. Dr. Brantley has worked on approximately 9 approved drugs, 3 NDAs, 5 INDs, 90+ PK and population PK analyses.